TrialMolecular therapy : the journal of the American Society of Gene Therapy2010

Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer.

Sant P Chawla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.